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INTRODUCTION 
Polymers are macromolecules having very large chains, 
contain a variety of functional groups, can be blended 
with other low- and high–molecular-weight materials, 
and can be tailored for any applications. Polymers are the 
backbone of pharmaceutical drug delivery systems. They 
have been found extensive applications in drug delivery 
because they offer unique properties which have not 
been attained by any other materials. Polymers have been 
used as a important tool to control the drug release rate 
from the formulations and they are also enhance used as 
stabilizer, taste-masking agent, and protective agent in 
oral drug delivery. Polymers can bind the particles of a 
solid dosage form and also change the flow properties of 
a liquid dosage form. 1Advances in polymers led to 
development of several novel drug delivery systems due 
to proper consideration of surface and bulk properties of 
polymers. Due to this reason, polymers have been widely 
used in developing new technologies by many 
researchers. These new technologies contribute to make 
medical treatment more efficient and side effects are also 
reduced. Polymer play an important role in the Drug 
delivery system in terms of materials to assist delivery, 
excipients, and technology which allow fast or slow 
release of drugs from the formulation.2  
Classification of polymers:- 
Based on source:- 
1. Natural:- Chitosan, Alginate, Gelatin, Albumin, 
Collagen, Dextran 
2. Semi-Synthetic:- Hydroxy Propyl Methyl Cellulose 
(HPMC), Methyl Cellulose (MC), Hydroxy Propyl 
Cellulose (HPC)    
3. Synthetic:-  Polyethylene, Polylactic acid, 
Polypropylene, Polyglycolic acid, Polyhydroxy Butyrate  
Type of Polymerization:- 
Addition Polymer:- Polyethylene, Polypropylene, 
Polyvinyl Chloride 
Condensation Polymer:- Polyurethane, Polyester 
Degradability:- 
Biodegradable:- Polylactic acid, Polyglycolic acid, 
Polycaprolactone,     Polyanhydrides 
Non-Biodegradable:- Polydimethyl Siloxane, Polyether 
Urethane, Ethyl Cellulose 
Nature of Polymer Water Interaction:- 
Hydrophobic Polymer:-  Ethyl Cellulose,  Polydiethyl 
Siloxane Hydrophilic Polymer :-  Cellulosic: MC, HPMC, 
HPC, HEC, NaCMC. Cellulosic: Sodium Alginate, 
Xanthun gum, chitosan Hydrogel Material :-  Cross-
linked Polyvinyl Alcohol, Polyethylene Oxide, 
Polyacrylamide3                                                                                                          
Role of polymers in drug delivery:-   
1. Immediate release dosage forms Tablets: Polymers 
including polyvinyl‐pyrrolidone and hydroxypropyl       
methylcellulose (HPMC) find uses as binders that aid the 
formation of granules that improve the flow and 
compaction properties of tablet formulations prior to 
tableting.      
Capsules: Many of the polymeric excipients used to 
“bulk out” capsule fills are the same as those used in 
immediate release tablets. Gelatine has been used almost 
exclusively as a shell material for hard (two‐piece) and 
soft (one‐piece) capsules. HPMC has recently been 
developed and accepted as an alternative material for the 
manufacture of hard (two‐piece) capsules.    
2. Modified‐release dosage form                                                                           
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To  achieve gastro retention mucoadhesive and 
low‐density , polymers have been evaluated, with little 
success so far, for their ability to extend gastric residence 
time by bonding to the mucus lining of the stomach and 
floating on top of the gastric contents respectively.                                                                    
3. Extended release dosage forms                                                                             
Extended and sustained release dosage forms prolong the 
time that systemic drug levels are within the therapeutic 
range and thus reduce the number of doses the patient 
must take to maintain a therapeutic effect thereby 
increasing compliance. The most commonly used 
water‐insoluble polymers for extended‐release 
applications are the ammonium ethacrylate copolymers 
(Eudragit RS and RL), cellulose derivatives 
ethylcellulose, and cellulose acetate, and polyvinyl 
derivative, polyvinyl acetate.                                                                                                                              
4. Gastroretentive Dosage Forms                                                                   
Gastroretentive dosage forms offer an alternative 
strategy for achieving extended release profile, in which 
the formulation will remain in the stomach for prolonged 
periods, releasing the drug in situ, which will then 
dissolve in the liquid contents and slowly pass into the 
small intestine.4 
TYPES OF POLYMERS IN PHARMACEUTICAL 
DRUG DELIVERY:                                                                                                                                                                                                                           
Polymers as floating drug delivery system                                                     
 
Polymers are generally employed in floating drug 
delivery systems so as to target the delivery of drug to a 
specific region in the gastrointestinal tract i.e. stomach. 
Natural polymers which have been explored for their 
promising potential in stomach-specific drug delivery 
include chitosan, pectin, xanthan gum, guar gum, gellan 
gum, karaya gum, psyllium husk, starch, alginates etc.5                           
Polymers used in mucoadhesive drug delivery system                                                  
The new generation mucoadhesive polymers for buccal 
drug delivery with advantages such as an increase in the 
residence time of the polymer, penetration enhancement, 
site-specific adhesion, and enzymatic inhibition, site-
specific mucoadhesive polymers will undoubtedly be 
utilized for the buccal delivery of a wide variety of 
therapeutic compounds. This class of polymers has 
enormous potential for the delivery of therapeutic 
macromolecules. Application of lectin and 
“lectinomimetics” appears to be the most promising area 
of current research efforts aimed at the safe and effective 
delivery of drugs via the buccal mucosa.6    
Polymers used as Colon Targeted Drug Delivery                                                       
Polymer plays a very important role in the colon targeted 
drug delivery system. It protects the drug from 
degradation or release in the stomach and small intestine. 
It also ensures abrupt or controlled release of the drug in 
the proximal colon. For examples Wong et al. studied the 
dissolution of dexamethasone and budesonide from guar 
gum-based formulations  and observed that the drug 
release in simulated colonic fluid was markedly 
increased at galactomannanase concentrations >0.01 
mg/ml. A novel colon targeted tablet formulation using 
pectin as a carrier and diltiazem hydrochloride and 
indomethacin as model drugs has been developed. In 
vitro study showed that prepared dosage forms have 
limited drug release in stomach and small intestine and 
released maximum amount of drug in the colon. McLeod 
et al. synthesized glucocorticoid-dextran conjugates in 
which dexamethasone and methylprednisolone were 
attached to dextran using dicarboxylic acid linkers 
(succinate and glutarate). Dextran conjugates resisted 
hydrolysis in upper GI tract contents but were rapidly 
degraded in cecal and colonic contents where the 
bacterial count is high. Chitosan capsules were used for 
colonic delivery of an antiulcerative colitis drug. 5-
Aminosalicylic acid (5-ASA) was used as model drug. A 
marked increase in the release of drug from chitosan 
capsule was observed in the presence of the rat cecal 
content.7 
Polymers for Sustained Release 
Polymer used in the sustain release system by preparing 
biodegradable microspheres containing a new potent 
osteogenic compound. In order to achieve the sustained 
release of 3-ethyl-4-(4-methylisoxazol-5-yl)-5-
(methylthio) thiophene- 2-carboxamide, a new potent 
osteogenic compound for the treatment of bone 
disorders, prepared a microspheres containing BFB0261 
and newly synthesized three poly (d, l-lactic acid) (PLA), 
four poly (d, l-lactic acid–co-glycolic acid) (PLGA), and 
eight poly (d, l-lactic acid)-block-poly(ethylene glycol) 
(PLAPEG) biodegradable polymers or copolymers, and 
evaluated the release pattern of microspheres.8 
Polymers in implantable drug delivery  
Polymer micro-needles are of interest for implantable 
drug delivery due to their enhanced biocompatibility, and 
capability to conform to tissue without shattering during 
the insertion or tissue reconfiguration processes. These 
devices have been fabricated using several polymers 
including polydimethylsiloxane (PDMS) ;), polylactic 
and polyglycolic acid (PLGA), block copolymer 
hydrogels , SU-8 photoresist , and polyimide . Bernardo 
et al 2010 developed a device that incorporates the 
flexibility and biocompatibility of polymer microneedles 
while still offering the advantages of active fluidic 
delivery devices in simple microfluidic architecture. This 
device uses a similar electrochemical release and dose 
control mechanism as our previous work (Chung and 
Erickson) but is now integrated into a flexible system as 
opposed to its silicon predecessor.9 
Polymeric micelles  
Polymeric micelles (PMs) are developed in response to 
the immediate needs of high selectivity of drug carriers. 
Nowadays many life threatening diseases, such as 
cancer, current chemotherapy of which, still face a most 
serious problem of lack of selectivity of anticancer drugs 
toward proliferative cells, thus, resulting in the cytotoxic 
action of these drugs. PMs formed from an amphiphilic 
block copolymer are suitable for encapsulation of poorly 
water-soluble, hydrophobic anticancer drugs. 
Importantly, critical features of the PMs as drug carriers, 
including particle size, stability, loading capacity and 
release kinetics of drugs allow PMs to be targeted to the 
tumor site by a passive mechanism called the enhanced 
permeability and retention effect.10 
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Polymers in tissue engineering  
A wide range of natural–origin polymers with special 
focus on proteins and polysaccharides might be 
potentially useful as carriers systems for active 
biomoleculesor as cell carriers with application in the 
tissue engineering field targeting several biological 
tissues.  
 Protein-based in the tissue engineering field are:- 
 collagen, 
  gelatin 
  silk fibroin, fibrin (fibrinogen) and 
  Other proteins such elastin or soybean are used. 
Several polysaccharides based polymers used in tissue 
engineering are:- 
 Chitosan 
 Starch 
 Alginate 
 Chondroitin sulphate 11 
Polymers used in micro and nanoparticles for 
targeted drug delivery 
Micro- and nanospheres fabricated from a biodegradable 
polymer for drug delivery systems have become 
increasingly important owing to the fact that such 
systems enable controlled drug release at desired sites. A 
number of polymers have been investigated for 
formulating biodegradable nanoparticles, such as 
polylactide (PLA), polycaprolactone (PCL) and poly 
(lactide-co-glycolide) (PLGA). These are biocompatible 
and biodegradable polymers which have recently been 
the subject of extensive investigation. Polymeric nano 
carriers such as poly (DL-lactide-co-glycolide) have 
shown promising pharmacokinetics both at the whole-
body and cellular levels (passive targeting). The active 
drug targeting is usually achieved by the chemical 
attachment onto a targeting component that strongly 
interacts with antigens (or receptors) displayed on the 
target tissue, leading to the preferential accumulation of 
the drug in the targeted organ, tissue, or cells .12 
Polymer drug conjugate 
Polymer–drug conjugates achieve tumour-specific 
targeting by the enhanced permeability and retention 
(EPR) effect these macromolecular prodrugs comprise a 
minimum of three components, : a natural or synthetic, 
water-soluble polymeric carrier (usually of 10 000–100 
000 Da), a biodegradable polymer–drug linkage (often a 
peptidyl or ester linkage) and a bioactive antitumour 
agent. Phase I/II clinical trials involving N-(2-
hydroxypropyl)methacrylamide (HPMA) copolymer-
doxorubicin (PK1; FCE28068) showed a four- to 
fivefold reduction in anthracycline-related toxicity, and, 
despite cumulative doses up to 1680 mg/m2 (doxorubicin 
equivalent), no cardiotoxicity was observed.13 
MECHANISM OF DRUG RELEASE FROM 
POLYMERS  
Diffusion 
Diffusion occurs when a drug or other active agent 
passes through the polymer that forms the 
controlled‐release device. Diffusion occurs when the 
drug passes from the polymer matrix into the external 
environment. As the release continues its rate normally 
decreases with this type of system since the active agent 
has a progressively longer distance to travel and 
therefore requires a longer diffusion time to release. In 
these systems, the combinations of polymer matrices and 
bioactive agents chosen must allow for the drug to 
diffuse through the pores or macromolecular structure of 
the polymer upon introduction of the delivery system 
into the biological environment without inducing any 
change in the polymer itself.14 
Degradation 
Biodegradable polymer degrades within the body as a 
result of natural biological processes, eliminating the 
need to remove a drug delivery system after release of 
the active agent has been completed. Most biodegradable 
polymers are designed to degrade as a result of 
hydrolysis of the polymer chains into biologically 
acceptable and progressively smaller compounds. For 
some degradable polymers, most notably the 
polyanhydrides and polyorthoesters, the degradation 
occurs only at the surface of the polymer, resulting in a 
release rate that is proportional to the surface area of the 
drug delivery system.15 
Swelling 
They are initially dry and when placed in the body will 
absorb water or other body fluids and swell. The 
swelling increases the aqueous solvent content within the 
formulation as well as the polymer mesh size, enabling 
the drug to diffuse through the swollen network into the 
external environment.16 
APPLICATIONS OF POLYMERS IN DRUG 
DELIVERY:- 
Application in conventional dosage forms:- 
1. Tablets:-As binders to mask unpleasant taste for 
enteric coated tablets  
2. Liquids:- Viscosity enhancers  For controlling the flow  
3. Semisolids:- In gel preparation  
4. In Ointments  
5. In transdermal Patches 17                                                                                
Application in biomedical field:-                            
                        
A. Water-Soluble Synthetic Polymers 
1. Poly (acrylic acid) Cosmetic, pharmaceuticals, 
immobilization of cationic drugs, base for Carbopol 
polymer. 
2.  Poly (ethylene oxide) as Coagulant, flocculent, very 
high molecular-weight up to a few millions, swelling 
agent             
3.  Poly (ethylene glycol) MW <10,000; liquid (MW 
<1000) and wax (MW >1000) as plasticizer, base for 
suppositories                 
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4. Poly (vinyl pyrrolidone) aUsed to make betadine 
(iodine complex of PVP) with less toxicity than iodine, 
plasma replacement, tablet granulation. 
5. Poly (vinyl alcohol) Water-soluble packaging, tablet 
binder, tablet coating Polyacrylamide Gel electrophoresis 
to separate proteins based on their molecular weights, 
coagulant, absorbent.    
             6. Poly (isopropyl acrylamide) and poly 
(cyclopropyl methacrylamide)   
B. Cellulose-Based Polymers 
1.   Ethyl cellulose Insoluble but dispersible in water, 
aqueous coating system for sustained release applications 
2. Carboxymethyl cellulose Super disintegrant, emulsion 
stabilizer 
3. Hydroxyethyl and hydroxypropyl celluloses  
4. Soluble in water and in alcohol, tablet coating 
5. Hydroxypropyl methyl cellulose Binder for tablet 
matrix and tablet coating, gelatin alternative as capsule 
material   
6. Cellulose acetate phthalate enteric coating  
  
C. Hydrocolloids    
               
1.  Alginic acid Oral and topical pharmaceutical 
products; thickening and suspending agent in a variety of 
pastes, creams, and gels, as well as a stabilizing agent for 
oil-in-water emulsions; binder and disintegrant 
2.  Carrageenan: - Modified release, viscosifier  
3. Chitosan:- Cosmetics and controlled drug delivery 
applications, mucoadhesive dosage forms, rapid release 
dosage forms                  
4. Hyaluronic acid Reduction of scar tissue, cosmetics 
5. Pectinic acid Drug delivery   
                   
D. Water-Insoluble Biodegradable Polymers 
Lactide-co-glycolide polymers Microparticle–
nanoparticle for protein delivery. 
E. Starch-Based Polymers                                                  
Starch Glidant, a diluent in tablets and capsules, a 
disintegrant in tablets and capsules, a tablet binder 
Sodium starch glycolate Super disintegrant for tablets 
and capsules in oral delivery 
F. Plastics and Rubbers   
1.Polyurethane Transdermal patch backing (soft, 
comfortable, moderate moisture transmission), blood 
pump, artificial heart, and vascular grafts, foam in 
biomedical and industrial products Silicones Pacifier, 
therapeutic devices, implants, medical grade adhesive for 
transdermal delivery 
2.Polycarbonate Case for biomedical and pharmaceutical 
products 
3. Polychloroprene Septum for injection, plungers for 
syringes, and valve components 
4. Polyisobutylene Pressure sensitive adhesives for 
transdermal delivery 
5. Polycyanoacrylate Biodegradable tissue adhesives in 
surgery, a drug carrier in nano- and microparticles            
6. Poly (vinyl acetate) Binder for chewing gum. 
7. Polystyrene Petri dishes and containers for cell culture
               
8. Polypropylene Tight packaging, heat shrinkable films, 
containers             
9. Poly (vinyl chloride) Blood bag and tubing. 
                         
10. Polyethylene Transdermal patch backing for drug in 
adhesive design, wrap, packaging, containers  
11. Poly (methyl methacrylate) hard contact Lenses Poly 
(hydroxyethyl methacrylate) Soft contact lenses 18                                                              
Applications of polymers for controlled drug delivery                                                                                                                       
1. Reservoir Systems 
2.   Ocusert System 
3.   Matrix Systems 
4.   Swelling Controlled Release Systems 
5.   Biodegradable Systems 
6.   Osmotically controlled Drug Delivery 
7.   Introduction: Principles of Controlled Drug Delivery 
8.   The Progestasert System 
9.   Reservoir Designed Transdermal Patches 
10.  Matrix Systems 
11.  Stimulus Responsive Drug Release 
12.  Ultrasound Responsive Drug Release 
13.  Temperature Responsive Drug Release 
14.  pH Responsive Drug Release 
15.  Electric Current Responsive Drug Release 
16.  Polymer-Drug Conjugates 19                                                                               
Future prospective of advanced drug delivery using 
polymers:-                        
Engineered Polymers for Advanced Drug Delivery                                               
Smart polymers: - Modern drug delivery technology 
has been made possible by the advances in polymer 
science. Advancement in polymer science and 
engineering has developed new polymers for well-
controlled delivery of therapeutic drugs. One of them 
will be the smart polymer (stimuli-sensitive polymer), 
which possesses active responsiveness to environmental 
signals and changes the physicochemical property as 
designed. Physical (temperature, ultrasound, light, 
electricity, mechanical stress), chemical (pH, ionic 
strength), and biological signals (enzymes, biomolecules) 
have been used as triggering stimuli.  
Smart polymeric systems                                                                                     
Passive targeting based on the EPR effect uses a unique 
physiological property of a disease (physiological 
targeting), while conjugation of targeting moiety to drug 
carriers is a biochemical targeting strategy. Smart 
polymeric systems also provide a targeting strategy, 
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which is activated and triggered by a specific 
environmental signal (triggered targeting)                                                                                            
Polymeric systems for molecular imaging                                                           
Advancement in imaging technology has shifted 
conventional invasive and anatomical diagnosis to non-
invasive and physiological/molecular imaging technique. 
Applying the molecular imaging technique to clinical 
imaging modalities, such as magnetic resonance imaging 
(MRI), positron emission tomography (PET), fluorescent 
optical imaging, and ultrasound imaging, however, has 
been hampered by poor sensitivity, specificity, and 
targeting ability of current imaging probes. Small 
molecules that are directly labeled with a wide range of 
chemicals have been limited in use due to their lack of 
specificity, instability, toxicity, and rapid clearance. 
Recently, combination of polymer chemistry and 
imaging realm has led to novel polymeric probes for 
clinical diagnosis. Polymeric probes for molecular 
imaging take all advantages of polymer-based drug 
delivery systems, which can significantly increase 
plasma half-life and blood stability, reduce systemic 
toxicity, and especially improve contrasting ability by 
introduction of targeting moiety 20 
CONCLUSION                                                                                 
The use of novel polymers not only offers benefits but 
also can prove to be harmful because of the toxicity and 
other incompatibilities associated with them. Care should 
be taken to properly select polymers while designing a 
delivery system. The ultimate goal is to introduce cost 
effective, biocompatible, multifunctional, less toxic 
polymers so that the delivery systems pass through the 
various phases of clinical trials and benefit the society.  
Among various types of polymer hydrogels, polymer 
blends of natural and/or synthetic polymers are used in 
the pharmaceutical formulations, in that controlled drug 
delivery systems having a advantages over conventional 
therapy fall into various categories such as diffusion-
controlled, chemically controlled, solvent activated and 
modulated release systems.  The new generation 
mucoadhesive polymers for buccal drug delivery With 
advantages such as an increase in the residence time of 
the polymer, penetration enhancement, site-specific 
adhesion, and enzymatic inhibition, site-specific 
mucoadhesive polymers will undoubtedly be utilized for 
the buccal delivery of a wide variety of therapeutic 
compounds for that lectin and “lectinomimetics” appears 
to be the most promising area of current research efforts 
aimed at the safe and effective delivery of drugs via the 
buccal mucosa. MIP [molecular imprinting] in fully 
aqueous environments, imprinting of very polar 
molecules and bio-macromolecules, mass transfer, 
binding site population, capacity and template bleed. On 
the whole, polymers are being extensively used in 
pharmaceutical industry due to their vast applications.
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